About COPD and asthma devices
COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals with breathing problems. These devices deliver an optimum dosage of medication directly to the site of action, preventing inflammation and constriction of the airways and minimizing symptoms. These devices include inhalers and nebulizers, most of which are handheld and portable.
Technavio's analysts forecast the global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global COPD and asthma devices market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following COPD and asthma devices:
• Inhalers
• Nebulizers
Technavio's report, Global COPD and Asthma Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Consort Medical
• Gerresheimer
• Nypro
• Philips Healthcare
• RPC Bramlage
Other prominent vendors
• Aerogen
• Airon
• Allied Healthcare
• AstraZeneca
• Boehringer Ingelheim
• Briggs Healthcare
• Cardinal Health
• Clement Clarke International
• DeVilbiss Healthcare
• Drive Medical
• GlaxoSmithKline
• Heyer Medical
• Invacare
• Omron Healthcare
• PARI Medical
• Salter Labs
• Smart Inhaler
• Sunovion Pharmaceuticals
• Teleflex
• Vortran Medical
Market driver
• Increased prevalence of respiratory disorders
• For a full, detailed list, view our report
Market challenge
• Regulatory issues
• For a full, detailed list, view our report
Market trend
• Advances in technology
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: COPD and asthma
Asthma
COPD
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market segmentation by product type
Inhalers
Nebulizers
PART 08: Global inhalers market
Market overview
PART 09: Global nebulizers market
Market overview
PART 10: Geographical segmentation
COPD and asthma devices market in Americas
COPD and asthma devices market in EMEA
COPD and asthma devices market in APAC
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
Advances in technology
Increase in online marketing services
Increase in awareness of COPD and asthma devices
PART 16: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 17: Key vendor analysis
Consort Medical
Gerresheimer
Nypro
Philips Healthcare
RPC Bramlage
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global COPD and asthma devices market ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global COPD and asthma devices market segmentation by product type
Exhibit 05: Segmentation of global COPD and asthma devices market by product type 2014
Exhibit 06: Global inhalers market 2014-2019 ($ millions)
Exhibit 07: Segmentation of global inhalers market by product type
Exhibit 08: Global DPI market 2014-2019 ($ millions)
Exhibit 09: Global MDI market 2014-2019 ($ millions)
Exhibit 10: Global SMI market 2014-2019 ($ millions)
Exhibit 11: Global inhalers market 2014-2019 ($ millions)
Exhibit 12: Segmentation of global nebulizers market by technology
Exhibit 13: Segmentation of COPD and asthma devices market by geography 2014
Exhibit 14: COPD and asthma devices market in Americas 2014-2019 ($ millions)
Exhibit 15: COPD and asthma devices market in EMEA 2014-2019 ($ millions)
Exhibit 16: COPD and asthma devices market in APAC 2014-2019 ($ millions)
Exhibit 17: Segmentation of global COPD and asthma devices market by geography 2014-2019 ($ millions)
Exhibit 18: Segmentation of the global COPD and asthma devices market by geography 2014-2019
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Consort Medical: Key takeaways
Exhibit 22: Gerresheimer: Key takeaways
Exhibit 23: Nypro: Key takeaways
Exhibit 24: Philips Healthcare: Key takeaways
Exhibit 25: RPC Bramlage: Key takeaways
Exhibit 26: Consort Medical: Business segmentation
Exhibit 27: Consort Medical: Business segmentation by revenue 2014
Exhibit 28: Consort Medical: Revenue segmentation by geography 2014
Exhibit 29: Gerresheimer: Business segmentation by revenue 2014
Exhibit 30: Gerresheimer: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 31: Gerresheimer: Segmentation of revenue by geography 2014
Exhibit 32: Nypro: Product segmentation
Exhibit 33: Philips Healthcare: Business segmentation by revenue 2014
Exhibit 34: Philips Healthcare: Segmentation of revenue by geography 2014
Exhibit 35: RPC Bramlage: Product segmentation
